Issue there is that implicitly U.S. R&D is subsidizing the rest of the world since we don’t negotiate prices but others do. Seems like an unfortunate trade-off between the present and the future/ here and other places, except when there is a lack of reinvestment of revenue into R&D.
I made the specific point about drug costs to support the general point that that things don’t have to become more expensive when purchased by governments.
I’m not quite sure what you’re asking, but state healthcare providers buy pharmaceuticals with public money and can get them cheap...outside the US.
Issue there is that implicitly U.S. R&D is subsidizing the rest of the world since we don’t negotiate prices but others do. Seems like an unfortunate trade-off between the present and the future/ here and other places, except when there is a lack of reinvestment of revenue into R&D.
I made the specific point about drug costs to support the general point that that things don’t have to become more expensive when purchased by governments.